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Abstract Although participation of matrix metalloprotein-
ases (MMPs) in reproductive tract remodeling has been
strongly suggested in mammalian species, the role of MMPs
in the avian oviduct has received little attention. To gain a
better understanding of the potential role of the MMP system
in avian oviduct development, mRNA and protein expression,
localization of selected MMPs and their tissue inhibitors
(TIMPs), and gelatinolytic activity in the oviduct of growing
chickens were examined. The oviducts were collected from
Hy-Line Brown hens before (10, 12, 14 and 16 weeks of age)
and after (week 17) the onset of egg laying. The MMP-2, -7, -
9 and TIMP-2 and -3 genes were found to be differentially
expressed in all examined oviductal sections: the infundibu-
lum, magnum, isthmus and shell gland on both mRNA (by
real time polymerase chain reaction) and protein (by western
blotting and immunohistochemistry) levels. In the course of
oviduct development, the relative expression of all genes de-
creased in most sections. Protein level of MMP-9 was dimin-
ished, while MMP-7 and TIMP-3 were elevated in the oviduct
of growing birds. MMP-2 and TIMP-2 protein levels
remained constant, with a slight increase in MMP-2 concen-
tration just before reaching maturity. The relative activity of
MMP-2 and -9 (assessed by gelatin zymography) was higher
(P<0.05, P<0.01) in immature birds compared with adults.
Immunohistochemistry demonstrated cell- and tissue-specific
localization of MMPs and TIMPs in the wall of the chicken
oviduct. We concluded that changes in the expression of
examined MMPs and their inhibitors, as well as alterations
in MMP activity occurring simultaneously with changes in
the morphology of the chicken oviduct, suggest the involve-
ment of the MMP system in the proper development and
functioning of this organ. Mechanisms regulating the expres-
sion and activity of MMPs require further clarification.
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Introduction
The extracellular matrix (ECM) is one of the most important
regulators of cellular physiology, providing an environment
for cell migration, proliferation, differentiation, and apoptosis
(Smith et al. 1999). Therefore, proper ECM remodeling seems
to be essential for tissue growth and morphogenesis.
Numerous studies have established that the key enzymes in-
volved in the control of ECM turnover and homeostasis are
matrix metalloproteinases (MMPs) (Page-McCaw et al. 2007;
Murphy and Nagase 2008; Kessenbrock et al. 2010).
Architectural features and substrate preference categorize
the MMP family members into several classes, i.e. the colla-
genases (MMP-1, -8, -13), gelatinases (MMP-2, -9),
stromelysins (MMP-3, -10, -11), matrilysins (MMP-7, -26),
membrane type MMPs (MT-MMP-1, -2, -3, -4, -5, -6), and
other less characterized members (Page-McCaw et al. 2007).
The gelatinases, stromelysins and matrilysins are capable of
degrading major constituents of basement membranes, includ-
ing type IV collagen, laminin and fibronectin (Senior et al.
1991; Nagase et al. 2006). In addition to the removal of un-
wanted ECM molecules, MMPs exhibit activity toward other
MMPs, growth factors and cytokines. It has become clear that
MMPs influence many cellular functions and so their activity
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may be necessary during development and normal physiology
(Fingleton 2003; Murphy and Nagase 2008, 2011; Page-
McCaw et al. 2007).
MMPs are initially expressed in an enzymatically inactive
state and require proteolytic cleavage by convertases, serine
proteinases or by other MMPs to become active (Sternlicht
and Werb 2001). The site and the extent of ECM remodeling
depend on the local balance between the MMPs and their
associated endogenous inhibitors. The physiological inhibi-
tors of MMP function are liver-derived α2-macroglobulin
and the tissue inhibitors of metalloproteinases (TIMPs).
TIMP-1, -2, -3, and -4 act selectively on different MMPs.
For example, TIMP-2 has a high affinity for MMP-2, whereas
TIMP-3 preferentially binds to MMP-9. Thus, the activity of
MMPs can be regulated at multiple levels: gene expression,
conversion from zymogen to active enzyme, and, eventually,
the presence of specific inhibitors (Murphy 2011).
The MMP system has been strongly suggested to play a
critical role in reproductive functions in humans and diverse
animal species (Curry and Osteen 2001; Gabler et al. 2001;
Bai et al. 2005). It has been postulated to regulate dynamical
structural changes that occur in the ovary and uterus. In addi-
tion, the expression of MMPs in reproductive tissues has been
reported to be cell-, tissue- and reproductive cycle-dependent
(Rodgers et al. 1993; Rudolph-Owen et al. 1998; Skinner et al.
1999; Määttä et al. 2000). Although the participation of MMP
family members in reproductive functions has been strongly
suggested in mammalian species, the evidence regarding
MMPs in the avian reproductive system is scarce. It is known
that certain MMPs and TIMPs are expressed in the chicken
ovary (Leśniak and Hrabia 2012; Zhu et al. 2014), whereas
information concerning the MMP system in the avian oviduct
is limited to the demonstration of MMP-2, -9 and TIMP-2 and
-3 mRNA expression in the chicken (Réhault-Godbert et al.
2008; Dunn et al. 2009; Song et al. 2011; Hrabia et al. 2013),
as well as the involvement of MMP-2 in the process of the
right Müllerian duct regression in the chicken embryo (Ha
et al. 2004).
The avian reproductive system differs from that of mam-
mals, and most of the compartments have widely different
anatomical and physiological features. In birds, the oviduct
consists of five diverse segments: infundibulum, magnum,
isthmus, shell gland (uterus), and vagina, each of which is
involved in specific biological events. During development
of the oviduct, the epithelial cells differentiate into tubular
gland cells, goblet cells and ciliated cells (Kohler et al.
1969). The tubular gland cells are formed in the magnum,
isthmus and shell gland, and these oviductal segments have
specific secretory functions for egg formation.
Considering the fact that the mechanisms orchestrating avi-
an oviduct development at the molecular level are only poorly
understood, the aim of this study was to examine the potential
involvement of some members of the MMP system in the
process of ECM remodeling in the avian oviduct during pu-
berty. Accordingly, mRNA and protein expression, and local-
ization of selectedMMPs (MMP-2, -7, -9) and TIMPs (TIMP-
2, -3), as well as gelatinolytic activity in the oviduct of grow-
ing chickens were determined.
Materials and methods
Experimental birds
Animal experiments were conducted according to research
protocols approved by the Local Animal Ethics Committee
in Kraków, Poland. Immature Hy-Line Brown chickens (layer
strain) were purchased at 9 weeks of age from a commercial
farm (Drobeco, Palowice, Poland). Hens were caged individ-
ually under a photoperiod of 14 L:10 D with free access to
commercial food (11.5 MJ·kg−1, 15 % protein) and water.
Birds were killed by decapitation at 10, 12, 14, 16 and
17 weeks of age, i.e., 7, 5, 3 and 1 week(s) before and at the
time of reaching maturity, evidenced by the first oviposition
(118±1.2 days; n=15 at 10 and 12 weeks, and n=6 at 14, 16
and 17weeks of age). The hens that laid eggs were decapitated
2 h after oviposition. The oviduct was rapidly isolated and
weighed, and these oviductal segments were collected: infun-
dibulum, magnum, isthmus and shell gland. Tissue samples
were immediately frozen in liquid nitrogen and kept at –80 °C
until determination of the protein expression of MMPs and
activity, or placed into RNAlater and stored at –20 °C until
total RNA isolation. The other tissue fragments were fixed in
freshly prepared 10 % (v/v) buffered (0.1 M phosphate buffer,
pH=7.6) formalin, processed, and embedded in paraffin wax
for subsequent localization of MMPs and TIMPs.
RNA isolation, cDNA synthesis and quantitative (q) PCR
Total RNA was extracted from the tissues using TRI-reagent
(MRC, Cincinnati, OH, USA) according to manufacturer’s
recommendations. RNA (2 μg from each tissue) was
reverse-transcribed with a High-Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Foster City, CA,
USA) including random primers. Samples were incubated in
a thermocycler (Mastercycler Gradient; Eppendorf, Hamburg,
Germany) according to the following thermal profile: 25 °C
for 10 min, 37 °C for 120 min and 85 °C for 5 min. The
obtained cDNAwas used for real-time qPCR for MMP-2, -7
and -9, and TIMP-2 and -3 in a 96-well thermocycler
(StepOne Plus; Applied Biosystems) according to the recom-
mended cycling program: 2 min at 50 °C, 10 min at 95 °C,
40 cycles of 15 s at 95 °C and 60 s at 60 °C. The multiplex
real-time qPCRs for the examined genes were performed in a
10-μl volume containing 5 μl TaqMan Gene Expression
Master Mix (Applied Biosystems), 0.5 μl TaqMan Gene
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Expression Assays with specific TaqMan MGB-probe and
one pair of primers designed by Applied Biosystems, 0.5 μl
of Eucaryotic 18S rRNAEndogenous Control (pair of primers
and TaqMan probe-labeled VIC/TAMRA as a reference gene;
Applied Biosystems), 3 μl water and 1 μl cDNA (10×diluted
sample after the reverse transcription). The TaqMan Gene
Expression Assay parameters are shown in Table 1. Each
sample was run in duplicate. A no-template control was in-
cluded in each run. Relative quantification of the investigated
genes was calculated after normalization with the 18S rRNA
transcript, and expression in the infundibulum of the 10-week-
old chickens as the calibrator by using the 2-ΔΔCt method.
Quantification was performed using StepOne integrated
software.
Western blot analysis
In order to examine the expression of MMPs at the protein
level, immunoblotting was performed. Tissues were homoge-
nized in lysis buffer (BioVision, Milpitas, CA, USA) and clar-
ified by centrifugation (10,000g, 5 min, 4 °C). The protein
content was estimated using Bradford protein assay (Bio-
Rad, Hercules, CA, USA) with bovine serum albumin
(BSA) as the standard. Aliquots containing 50 μg of total
protein were mixed with loading buffer under reducing con-
ditions and subjected to SDS-PAGE using 12 % polyacryl-
amide gels (TGX FastCast acrylamide kits; Bio-Rad) and
Mini-Protean Tetra Cell apparatus. Resolved proteins were
transferred onto nitrocellulose membrane utilizing iBlot Gel
Transfer System (Life Technologies, Austin, TX, USA). The
membranes were then blocked with 5 % BSA and incubated
(overnight at 4 °C) with rabbit anti-MMP-2 (Abcam,
Cambridge, UK), rabbit anti-MMP-7 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), rabbit anti-MMP-9
(Abcam), rabbit anti-TIMP-2 (Santa Cruz Biotechnology) or
rabbit anti-TIMP-3 polyclonal antibodies (Abcam) at 1:2000
dilution, followed by incubation with goat anti-rabbit HRP-
conjugated antibody at 1:10,000 dilution. The bands were
visualized using enhanced chemiluminescence (Advansta,
CA, USA), ChemiDoc-It 410 imaging system and
VisionWorks Life Science software. As an internal control,
western blotting with mouse monoclonal anti-β-actin HRP-
conjugated IgG (1:500; Santa Cruz Biotechnology) was per-
formed. In negative controls, primary antibodies were
omitted.
Immunohistochemistry
Microtome sections (6 μm thick) were deparaffinized in xy-
lene and rehydrated by passing through graded alcohols. After
washing with TBST buffer (Tris buffer saline+0.1 % Tween
20), slices were incubated in citric buffer (pH=6.0, 75 °C,
20 min) for heat-induced antigen retrieval. Endogenous per-
oxidase activity was quenched in 3 % H2O2 in methanol
(10 min). Nonspecific binding of the secondary antibody
was blocked by incubation with 5 % (v/v) normal goat serum
in TBST (RT, 40 min). Sections were then incubated over-
night with primary rabbit polyclonal antibodies against
MMPs and TIMPs as described for western blots above.
After rinsing with TBST, sections were incubated (1.5 h) with
biotinylated goat anti-rabbit antibody (1:300) followed by
avidin-biotin-horseradish peroxidase complex (Vector
Laboratories, Burlingame, CA, USA) (30 min). The color
reaction was developed by incubation with diaminobenzidine
(DAB) and H2O2 solution. Non-specific staining was demon-
strated by replacement of the primary antibody with TBST.
Slides were examined under a light microscope (Jena Zeiss,
Germany).
Histochemistry
Additionally, for outlining structures such as connective tissue
and basement membrane in the wall of the oviduct, the
Periodic acid–Schiff’s staining (PAS; Sigma, St. Louis, MO,
USA) was performed for 10 min and 15 min, respectively.
Electrophoretic transfer gelatin zymography
Gelatinolytic activity within oviduct tissue homogenates was
determined using transfer zymography as described previous-
ly by Pan et al. (2011). Briefly, samples (50μg of total protein)
containing proteolytic enzymes were first resolved in nonre-
ducing SDS–PAGE on a 10 % gel without substrate. The
proteins in the resolving gel were then electrophoretically
Table 1 TaqMan probe sequences and size of amplicons generated by real-time polymerase chain reaction assay for chicken MMP-2, -7 and -9, and
TIMP-2 and -3 in the chicken oviduct
Gene Genbank accession no. TaqMan probe (FAM5’→3’NFQ) Amplicon (bp)
MMP-2 UO7775.1 CCTGGCCCTGGTCCTG 69
MMP-7 NM_001006278.1 TACAATCAAGGAGTTAATTTGTTCC 92
MMP-9 NM_204667.1 AGTACCTCTATGGTCGTGGCTCTGG 78
TIMP-2 NM_204298.1 ATCGCCCTCGGATTTG 88
TIMP-3 NM_205487.2 ACGCGGCCTGTAATC 70
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transferred, using Invitrogen gel transfer system, to a previ-
ously prepared gel with a copolymerized gelatin (0.5 mg/ml).
The receiving gel was then washed 3 times for 15min in 2.5%
(v/v) Triton X-100 with gentle shaking to remove SDS and
incubated at 37 °C overnight in developing buffer (50 mM
Tris-HCl, 10 mM CaCl2, 200 mM NaCl, 0.05 % NaN3,
pH 7.5). Subsequently, the gel was stained with 0.5 % (w/v)
Coomassie Brilliant Blue R-250 and destained in distilled wa-
ter until clear bands indicating gelatinolytic activity became
visible. An extended-range protein ladder was used for mo-
lecular weight estimation of the bands. Negative control
consisted of 12 mM 1,10-phenanthroline or 10 mM EDTA
(chelates Zn2+ and Ca2+) added to renaturing and developing
buffer before gel incubation.
Statistical analysis
Data were statistically analyzed by two-way ANOVA follow-
ed by Duncan’s multiple range test. Log transformations were
performed as needed tomaintain homogeneity of variance and
normality. For comparison of the means of two groups, the
Student’s t test was applied. Differences of values were con-
sidered to be significant at P<0.05. Calculations were per-
formed with Sigma Stat 2.03 (Systat Software, Germany).
Results are presented as means ± SEM.
Results
Messenger RNA expression of MMPs and TIMPs
in the chicken oviduct during maturation
Each of the studied genes was expressed in the chicken ovi-
duct during sexual maturation. The expression of MMP sys-
tem members was found to be age- and oviductal section-
dependent. The relative expression (RQ) of MMP-2, -7, -9
and TIMP-2 and -3 mRNA is shown in Fig. 1a-e.
As shown in Fig. 1a, the expression of MMP-2 was highest
in the infundibulum and lowest in the magnum. A relatively
high level of MMP-2 mRNA noted in the oviductal segments
in 10-week-old chickens decreased (P<0.05) in the isthmus
and shell gland by 51 and 21 %, respectively. At the age of
14 weeks, expression of MMP-2 declined (P<0.05) in all
segments (infundibulum by 50 %, magnum by 52 %, isthmus
by 47 %, and shell gland by 36 %). At the following stage of
the development (16 weeks), the expression of MMP-2 was
down-regulated only in the magnum (by 54 %) when com-
pared to the 14-week-old chicks. Finally, magnum and isth-
mus of 17-week-old laying hens showed lower (P<0.05)
MMP-2 mRNA levels (by 60 and 35 %) than that of chickens
at 16 weeks.
The expression of MMP-7 in the developing oviduct
was most abundant in the infundibulum, whereas it was
lowest in the isthmus (Fig. 1b). Between the ages of 10
and 12 weeks, an increase (P<0.01) in the MMP-7 ex-
pression was noted in the shell gland (by 194 %), while
the expression in other oviductal parts tended to de-
crease. In birds between 12 and 14 weeks of age, the
mRNA level diminished (P<0.01) substantially in all of
the examined sections: the infundibulum (by 73 %),
magnum (by 91 %), isthmus (by 94 %) and shell gland
(by 96 %), and became barely expressed. In 16-week-
old hens, the expression of MMP-7 mRNA was raised
(P<0.001) in the isthmus by 900 %. In mature birds,
the level of MMP-7 mRNA remained unchanged
(Fig. 1b).
The highest relative expression of MMP-9 was de-
tected in the infundibulum and the lowest in the shell
gland (Fig. 1c). Between 10 and 12 weeks of age
(P<0.05), a decrease in the MMP-9 mRNA level was
observed in the isthmus (by 47 %). As in other MMPs
tested, a tremendous reduction (P<0.05; P<0.01) in the
expression of MMP-9 was noted between 12 and
14 weeks in all the sections: the infundibulum (by
97 %), magnum (by 86 %), isthmus (by 84 %), and
shell gland (by 65 %). At the following stage of devel-
opment (16 weeks), the expression of MMP-9 did not
vary when compared to the 14-week-old chicks, al-
though in laying hens an increase (P<0.01; P<0.05)
in the magnum and shell gland was observed, by 255
and 57 %, respectively (Fig. 1c).
TIMP-2 showed a similar expression profile to MMP-
2, with the highest mRNA level in the infundibulum
and the lowest in the magnum (Fig. 1d). The highest
relative expression of TIMP-2 was revealed at the ages
of 10 and 12 weeks, and substantially declined
(P<0.05; P<0.01) at week 14 in the infundibulum,
magnum and shell gland by 55, 40, and 72 %, respec-
tively. What is interesting is that the TIMP-2 mRNA
level reduced (P<0.05) in the magnum of 16-week-old
chicks by 37 %, while it increased (P<0.01) in the shell
gland by 121 %. Similarly, in laying hens, the expres-
sion of TIMP-2 dropped (P<0.05) in the magnum and
isthmus (by 44 and 37 %), whereas it was up-regulated
(P<0.05) in the shell gland (by 47 %) (Fig. 1d).
The highest relative expression of TIMP-3 was de-
tected in the infundibulum of pullets at 10 weeks and
the lowest was observed in the magnum and isthmus of
17-week-old hens (Fig. 1e). A meaningful drop
(P<0.05) of the TIMP-3 mRNA was detected between
10 and 12 weeks of age in the infundibulum by 51 %,
isthmus by 72 %, and shell gland by 70 %. At the
following stages of development, the expression did
not vary substantially (P>0.05) until 17 weeks, when
it declined (P<0.05) in the magnum by 62 % and rose
in the shell gland by 103 % (Fig. 1e).
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Protein expression of MMPs and TIMPs in the chicken
oviduct during maturation
The developmental changes in MMP-2, -7, -9 and TIMP-2
and -3 protein levels in the chicken oviduct were detected by
western blot. All examined elements of MMP system were
identified in oviductal tissues, and their amount was depen-
dent on oviductal segments and the age of birds (Figs. 2a, 3a).
At each developmental stage, both latent (72 kDa) and active
(66 kDa) forms of MMP-2 were detected (Fig. 2a). The
highest relative level (sum of both forms) was in the infundib-
ulum and isthmus, and the lowest in the magnum. Moderate
expression of protein observed in the oviduct of 10- and 12-
week-old chickens increased (P<0.05; P<0.01) in the infun-
dibulum at the age of 14 weeks by 65 %, and at 16 weeks in
the magnum and isthmus by 115 and 164 %, respectively. In
Fig. 1 Expression of MMP-2 (a), MMP-7 (b), MMP-9 (c), TIMP-2 (d)
and TIMP-3 (e) mRNAs in the chicken oviduct during maturation. Data
represent the mean of relative quantity (RQ) ± SEM from a minimum of
six chickens standardized to expression in the infundibulum of 10-week-
old birds. Values marked with different letters differ significantly
(P<0.05)
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Fig. 2 Western blot analysis of
MMP-2, -7 and -9 proteins in the
chicken oviduct during
maturation. aRepresentative blots
of a minimum of 3 independent
determinations. b–d
Densitometric analysis for
MMPs. The relative expression of
each protein was evaluated with
densitometry and expressed as the
ratio relative to β-actin. Each
value represents the mean ± SEM
from a minimum of 3
determinations; values marked
with different superscript letters
differ significantly (P<0.05)
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laying hens, an elevation of protein level by 49 % was found
in the shell gland (Fig. 2b).Moreover, in chickens at the age of
16 and 17 weeks, an increase in active form of MMP-2 was
observed, especially in the isthmus (Fig. 2a).
During maturation, the presence ofMMP-7 protein, mainly
its active form (~20 kDa), was found in the chicken oviduct
(Fig. 2a). In several samples of the magnum and isthmus, an
additional band (~32 kDa) corresponding to the latent form of
MMP-7 was also observed. The highest MMP-7 protein level
was detected in the magnum and the lowest in the infundibu-
lum and shell gland. Very low levels ofMMP-7 detected in the
oviduct of 10- and 12-week-old birds increased (3-fold) in the
magnum and shell gland of 14-week-old hens. The most pro-
nounced increase (P<0.001) in protein expression occurred in
16-week-old birds in the infundibulum (22-fold), magnum
(33-fold), isthmus (35-fold) and shell gland (5-fold). After
maturation, there was no change inMMP-7 protein expression
(Fig. 2a, c).
MMP-9 protein was foundmainly in active form (~82 kDa)
in the oviduct of growing chickens (Fig. 2a). Between 10 and
14 weeks of age, the relative levels of MMP-9 protein were
relatively high in all parts of the oviduct, and at the following
stage decreased (P<0.01) in the infundibulum by 83 %, mag-
num by 96 % , and shell gland by 92 % (Fig. 2d).
TIMP-2 protein (~21 kDa) was also detected in chicken
oviduct duringmaturation (Fig. 3a). It was present at relatively
low levels in all segments of the oviduct and did not change
(P>0.05) during the examined period (Fig. 3b).
TIMP-3 protein was found in glycosylated (~30 kDa) and
unglycosylated (~24 kDa) forms (Fig. 3a). At the age of
10 weeks, the moderate expression of TIMP-3 protein was
observed, and it increased (P<0.05) at the age of 14 weeks
in themagnum by 156%, andmarkedly increased (P<0.01) at
the age of 16 weeks in the infundibulum, magnum and isth-
mus by 66, 200 and 195 %, respectively (Fig. 3c). After mat-
uration, TIMP-3 protein levels decreased (P<0.05) in the in-
fundibulum by 25 % and magnum by 16 %. In 16- and 17-
week-old chickens, the unglycosylated form of TIMP-3 was
mainly detected, and seen especially in the magnum and
isthmus which were characterized by the highest levels
of TIMP-3.
PAS staining and immunohistochemical localization
of MMPs and TIMPs in the chicken oviduct
during maturation
A slight increase in oviductal weight (g) was observed from
10 to 14 weeks of age (0.12±0.01→2.22±1.06) followed by
a sharp increase at 16 weeks (30.3±6.78). At 17 weeks, i.e., at
the time of sexual maturity, the weight of the oviduct was 50.5
±4.29.
Developmental changes which occurred in the structure of
the wall of the chicken oviduct are demonstrated in Fig. 4a–c.
The magnum was shown as a representative segment of the
oviduct. Since between 10 and 14 weeks of age, the changes
in the wall of the oviduct were very slight; the micrographs
from birds at the age of 12 weeks were chosen as an example.
The wall of immature birds consisted of poorly differentiated
luminal epithelium, the stroma under epithelium and layer of
smooth muscles interspersed with connective tissue (Fig. 4a).
In chickens at the age of 16 weeks, differentiating cells of
tubular glands and epithelium were observed (Fig. 4b), and
in 17-week-old birds (matured), all structures characteristic of
a fully developed organ were present (Fig. 4c).
Fig. 3 Western blot analysis of TIMP-2 and -3 proteins in the chicken
oviduct during maturation. a Representative blots of a minimum of 3
independent determinations. b, c Densitometric analysis for TIMPs.
The relative expression of each protein was evaluated with
densitometry and expressed as the ratio relative to β-actin. Each value
represents the mean ± SEM from a minimum of 3 determinations; values
marked with different superscript letters differ significantly (P<0.05)
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In immature 10- to 14-week-old birds, PAS staining
allowed observation of the connective tissue including the
base membrane (Fig. 4a), and, in 16- and 17-week-old hens,
additional intense staining was present in the apical part of the
epithelium and in the cells of tubular glands, which may indi-
cate a significant amount of proteoglycans synthesized and
secreted by epithelial and tubular gland cells (Fig. 4b, c).
Moreover, a different intensity of PAS staining in connective
tissue of particular segments of the oviduct was observed
which may indicate differences in this tissue composition de-
pendent on the oviductal part.
Specific immunoreactivity for MMPs and TIMPs was
found in the wall of all segments of the growing chicken
oviduct. Localization of MMPs and TIMPs is demonstrated
in the magnum as an example (Fig. 4d–s). Distinct cell- and
tissue-specific patterns of the localization of MMPs and
TIMPs were observed during puberty.
The intensity of staining for MMP-2 and TIMP-3 proteins
in immature birds was highest in the mucosa, but in laying
hens it was present only in the mucosal epithelium. Moderate
immunopositive reaction for MMP-7 and TIMP-2 was ob-
served in the wall of the juvenile oviduct, whereas a very
Fig. 4 PAS staining (a–c) and
immunohistochemical
localization of MMPs (d–l) and
TIMPs (m–s) in the wall of the
oviductal magnum during sexual
maturation of chicken. a PAS
staining showed connective tissue
(Ct) and b, c substances produced
by the cells of epithelium (E) and
tubular glands (Tg). d, g, m, p
MMP-2, -7, TIMP-2 and -3 were
present in the epithelium and
stroma (S) of 12-week-old birds,
whereas jMMP-9 was localized
in external part of stroma. e, h, n,
r Examined elements of MMP
system were found in the
epithelium and developing
tubular glands of 16-week-old
chickens, except kMMP-9 in
which localization was limited to
connective tissue. f, s In 17-week-
old laying hens, MMP-2 and
TIMP-3 were present in the
epithelium, while i, oMMP-7 and
TIMP-2 were present in the
epithelium and tubular glands. l
MMP-9 was localized only in the
connective tissue. Bars 100 μm
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strong staining, especially for MMP-7, appeared in the devel-
oping tubular glands of 16-week-old chickens, as well as api-
cally in mucosal epithelium of mature 17-week-old birds. In
immature chicks, the MMP-9 was localized in a large amount
in the mucosa except for the mucosal epithelium, while in 16-
week-old and adult hens MMP-9 was clearly present only in
the connective tissue.
Gelatinolytic activity of MMPs in the chicken oviduct
during maturation
Gelatinase zymography detected latent (~72 kDa) and active
(~66 kDa) forms of MMP-2, both in immature and mature
chickens (Fig. 5a). During maturation, the activity of MMP-
2 decreased (P<0.05, P<0.01). In the oviduct of laying hens
(17-week-old) the relative activity of MMP-2 was lower than
in 10-week-old chickens: in the infundibulum by 22 %, in the
magnum by 77 %, in the isthmus by 46 %, and in the shell
gland by 63 % (Fig. 5b).
Zymography also showed the presence of latent (~94 kDa)
and active (~82 kDa) forms of MMP-9 in the oviduct of 10-
week-old pullets, whereas in 17-week-old hens, activity of
MMP-9 was under the sensitivity of the method (Fig. 5a).
Moreover, in immature chickens, the presence of two bands
of approximately 60 and 50 kDa was detected, which suggests
latent and active forms of MMP-1 (Fig. 5a).
Discussion
The present study demonstrates, for the first time, the expres-
sion of MMP-2, -7 -9 and TIMP-2 and -3 at mRNA and
protein levels as well as activity ofMMP-2 and -9 in particular
segments of the chicken oviduct during maturation. Existing
data related to MMPs were fragmentary and revealed only the
presence ofMMP-2, -9 and TIMP-2 and -3 transcripts in some
parts of the chicken oviduct (Réhault-Godbert et al. 2008;
Dunn et al. 2009; Song et al. 2011; Hrabia et al. 2013).
In general, several weeks before sexual maturity, using the
method of real-time PCR, the highest expression level of ex-
amined MMPs and TIMPs was detected in 10-week-old
chickens and it tended to decrease during the maturation pe-
riod. MMP-2 and TIMP-2 and -3 demonstrated a similar ex-
pression pattern with the most eminent drop of the mRNA
expression between 12 and 14 weeks, or 10 and 12 weeks in
the case of TIMP-3. A distinct profile of the expression was
observed for MMP-7 and -9, with barely detectable mRNAs
in the oviduct of 14-week-old and older chickens. Previously,
Song et al. (2011) had found that, among genes in which
expression changed during growth, development and differ-
entiation of the oviduct, were MMP-2 and -9. They observed
that the MMP-2 mRNA level decreased during maturation,
whereas MMP-9 increased, but only in birds with a partly
differentiated oviduct. Similarly, in our study, levels of
MMP-2 and -9 transcripts decreased in all oviductal parts
between 10 and 14 weeks of age. In mature birds, expression
of MMP-9 mRNA increased in the magnum and shell gland.
Dunn et al. (2009) examined transcriptional profiles of genes
in the shell gland of immature (12-week-old) and mature (25-
week-old) chickens and found that, among 266 genes, TIMP-
3 was showing differentiating expression and its mRNA ex-
pression was higher in adult birds. Similar observations were
noticed in the current study when comparing levels of tran-
scripts in the shell gland of 12- and 17-week-old birds. Also,
in the uterus of mice, the differences in MMP and TIMP
transcript levels were revealed during embryonic and postna-
tal development (Hu et al. 2004; Nuttall et al. 2004). The
expression ofMMP-2 and TIMP-3 in the uterus was relatively
high, inhibitor TIMP-2 showed moderate expression, and the
presence of the transcripts for MMP-7 and -9 was negligible.
The results obtained in this investigation similarly show a very
low expression of MMP-7 and -9 in most sections of the
oviduct.
Another important observation was the determination of
differential expression of MMPs and their inhibitors among
oviductal sections, which is in accordance with the finding of
Réhault-Godbert et al. (2008), who also showed differences in
Fig. 5 Gelatinase activity in the oviduct of chickens at the age of 10 and
17 weeks. a Representative zymograms. I infundibulum, M magnum, Is
isthmus, SG shell gland. b Densitometric analysis for MMP-2 activity.
Each value represents the mean of relative activity (%) ± SEM from a
minimum of 3 determinations standardized to control activity, which was
set at 100 %, in the infundibulum of 10-week-old chickens. *P<0.05,
**P<0.01 compared with 10-week-old birds
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the level of mRNA expression of MMP-2 and TIMP-2 and -3
among particular segments of the oviduct of the laying hen.
These differences may result from the specific structure, cell
populations and functions of the various segments of the ovi-
duct. Relatively high expression in the infundibulum can be
associated with a large proportion of connective tissue and
muscles in this section, which were revealed to be character-
ized by a high level of transcription of elements of the MMP
system (Hu et al. 2004; Nuttall et al. 2004). Furthermore, the
relatively low level of transcripts in the magnum, at least in
part, may be due to the transcription process being dominated
by the genes encoding the proteins included in the egg white.
In this study, the expression of all tested components of the
MMP system at the protein level was also shown in the chick-
en oviduct during maturation. In the case of MMP-7 and
TIMP-3, a significant increase in protein level was observed
in 16-week-old birds, which may be related to the differenti-
ation of tubular gland cells that appeared at this stage of ovi-
duct development. Of particular interest in this work, the
MMP-2, -7 and TIMP-3 protein levels increased in most of
the sections of the oviduct during maturation in contrast to
expression at the mRNA level. A discrepancy between the
expression level of the protein and mRNA could be caused,
at least in part, by posttranscriptional regulatory mechanisms.
Over the past several years, it has been demonstrated that the
expression of genes and organ development, including the
reproductive ones (Sirotkin et al. 2009, 2010; Nothnick
2012), are largely regulated by micro-RNAs (mi-RNAs).
The inability of the female to maintain pregnancy has been
associated with the lack of molecules of mi-17-5p and let7b,
which control the expression of the inhibitor TIMP-1 (Otsuka
et al. 2008). In other studies, the ability ofmiR-29 to inhibit the
expression of several types of collagen and to stimulate the
expression of MMP-2 and -9 has been observed (Chen et al.
2011). The possibility cannot be excluded that the molecules
of mi-RNA affect the posttranscriptional regulation of MMPs
in the tissues of the oviduct in the chickens during sexual
maturation. However, despite the discovery of several mi-
RNAs involved in the mechanisms regulating growth and dif-
ferentiation of the hen oviduct (Jeong et al. 2012), there are as
yet no identified molecules which are capable of affecting the
expression of MMPs in this organ in birds.
The method of immunodetection and zymography con-
firmed the presence of both forms of MMP-2, latent and ac-
tive, in the oviduct of growing chickens. Expression of MMP-
2 at the protein level increased during maturation while the
activity of this metalloproteinase decreased in the oviduct.
This may indicate the existence of mechanisms that regulate
the activity of this enzyme in the chicken oviduct. One reason
for the reduced activity of MMP-2 could be an insufficient
amount of inhibitor TIMP-2, the protein level of which was
not changed during the examined period. TIMP-2 is essential,
not only for inhibition but also for the activation of pro-MMP-
2 (Wang et al. 2000; Cantemir et al. 2004). Similarly, activa-
tion of MMP-2 is carried out with TIMP-3 (Zhao et al. 2004),
and its expression at the protein level increased significantly
during the development of the hen oviduct. It cannot be ruled
out that other factors regulate the activity of MMP-2, such as
claudins, the presence of which has been found in the avian
oviduct (Ariyadi et al. 2013) andα2-macroglobulin. Lim et al.
(2011) found a high mRNA expression of α2-macroglobulin
in the hen oviduct, especially in the tubular glands and epithe-
lium, while it was absent in other examined organs such as the
brain, heart and ovaries. Among the sections of oviduct, the
greatest expression of this non-specific protease inhibitor was
observed in the magnum, and to a lesser extent in the isthmus
and the shell gland. A high level of α2-macroglobulin expres-
sion in those sections may indicate its role in controlling pro-
teolytic activity (Nagase and Harris 1983). Both protein ex-
pression and activity of MMP-9 declined markedly in the
oviduct during maturation of chickens. A significant amount
of MMP-9 present between 10 and 14 weeks of age strongly
suggests its participation in the processes occurring at the
early stages of the oviduct development. Previously, Hu
et al. (2004) revealed the presence and activity of MMP-2
and -9 in the mouse uterus during development and, similarly,
as in the present study in the chicken oviduct, observedmostly
the active form of MMP-9.
Subsequently, cell-specific and tissue-specific localization
of examined components of theMMP systemwas observed in
the wall of the oviduct. MMP-9 was located predominantly in
the connective tissue, while MMP-2 was in the stroma as well
as in epithelial and glandular cells. These cells may therefore
be responsible for the synthesis and secretion ofMMP-2 to the
lumen of the oviduct. MMP-2 may then become one of the
components of the egg white, since the presence of pro-MMP-
2 has been found in both the oviductal fluid and egg white
(Réhault-Godbert et al. 2008). The authors identified a pro-
MMP-2 in the egg protein in a complex with an inhibitor
TIMP-2, although the physiological role of this enzyme is still
unclear. The presence of MMP-7 was exclusively found in the
cells of epithelium and tubular glands. Inhibitors TIMP-2 and
-3 were located in the epithelium and in a small amount in the
stroma. Furthermore, the intensity of immunoreactivity for the
tested elements of the MMP decreased with the age of the
chickens, with the exception of MMP-7, for which the inten-
sity of the reaction increased during maturation. Similarly, Hu
et al. (2004) demonstrated cell- and tissue-specific localization
of MMPs in the wall of the mouse uterus during its develop-
ment. In turn, Huh and Jung (2013) observed a decrease in the
intensity of immunohistochemical reaction for TIMP-2 in the
testes of cocks during puberty.
Changes in the expression and activity of MMPs in the
chicken oviduct during sexual maturation strongly indicate
that they participate in the processes occurring during the
growth and differentiation of this organ. Inherent in tissue
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morphogenesis is the reconstruction of the components of the
ECM, a metalloproteinase domain. Thus, these enzymes can
be essential for the migration of cells through the degradation
of ECM components, for changes in the behavior of cells by
modification of their microenvironment, and for modulation
of molecule activity. It has been shown that inhibition of
MMP-2 minimizes the migration of adipocytes and the ability
to organize in three-dimensional structures (Brown et al.
1997). The lack of activity of MMP-2 also prevents the for-
mation of islets of Langerhans by endothelial cells, without
affecting their differentiation (Miralles et al. 1998). So one of
the aspects of MMP-2 during development of the chicken
oviduct could be its participation in the process of tubular
gland formation. This suggestion is supported by its localiza-
tion in the cells of glandular mucosa of 16-week-old birds.
Furthermore, Vaillant et al. (2003) observed that blocking of
the MMP-9 function by using a specific antibody reduces cell
migration in the developing cerebellum and reduces their sus-
ceptibility to apoptosis. Moreover, MMP-9 and TIMP-3 were
shown as the key regulators of the degradation of ECM in the
uterus of mouse embryos during implantation (Whiteside et al.
2001). It has also been shown that blocking ofMMP-9 inhibits
the development of renal glomerules and inhibition of the
expression of TIMP-2 stimulates the process (Lelongt et al.
1997). Intense immunoreactivity for MMP-9 observed in the
stroma adjacent to the epithelium in pullets between 10 and
14 weeks of age may suggest its involvement in the degrada-
tion of ECM and the formation of the mucosa in the hen
oviduct. Co-localization of MMP-9 with TIMP-2 and -3
may indicate the role of these inhibitors in the control of
MMP-9 activity, and in consequence the location and extent
of tissue remodeling. The observed increase in MMP-7 ex-
pression at the protein level and its localization in the tubular
glands of 16- and 17-week-old birds may be associated with
oviductal development. Previous studies have shown that
mice deficient in the CD44 antigen, which is a receptor
docking MMP-7 on the cell surface, have breast abnormalities
resulting from the wrong location of the enzyme (Murphy and
Nagase 2011; Bonnans et al. 2014). This observation empha-
sizes the great importance not only of the appropriate level of
expression of MMPs but also their location.
Metalloproteinases may also largely determine the activity
of biologically relevant molecules by disconnecting them
from binding proteins or releasing them from the places of
storage in the ECM and thus affecting the development of
the avian oviduct. For example, digestion of decorin by
MMP-2 and -7 releases the associated transforming growth
factor β (TGFβ; Imai et al. 1997), which in turn controls the
proliferation, differentiation and apoptosis of most cell types
(Conery et al. 2004; Elliott and Blobe 2005). In the chicken,
several isoforms of TGFβ and their receptors have been iden-
tified (Chowdhury et al. 2003, 2004) and participation of
TGFβ in oviductal growth, differentiation and morphogenesis
as well as immunosuppression has been suggested (Huang
and Huang 2005; Das et al. 2006). Hence, the involvement
of MMPs in the development of the oviduct of birds may be
associated with the regulation of the availability of TGFs.
Through release from binding proteins, MMPs can also
regulate the bioavailability of growth factors such as insulin-
like growth factors (IGFs) which influence the tissue growth.
It has been found that MMP-2 has activity against insulin-like
growth factor-binding proteins 3 and 5 (IGFBP-3 and -5)
(Fowlkes et al. 1994; Thrailkill et al. 1995), while both
gelatinases are capable of proteolytic activation of TGFβ
and IL-1β (Yu and Stamenkovic 2000). Recent studies by
Yu et al. (2015) showed that IGF-I stimulates proliferation of
myoblasts and development of muscles in chicken embryos.
During the development of the quail oviduct, Kida et al.
(1994) observed that high expression of IGF-I was accompa-
nied by intensification of DNA replication. In vitro experi-
ments have also shown that IGF-I stimulates the synthesis of
ovalbumin in the quail oviduct (Kida et al. 1995). Therefore, it
cannot be ruled out that the role of MMPs in the oviduct of
birds is associated with the regulation of the activity of IGFs.
In summary, reported changes in the expression of exam-
inedMMPs and their inhibitors, as well as alterations in MMP
activity occurring simultaneously with changes in the mor-
phology of the chicken oviduct, suggest the involvement of
the MMP system in the proper development and functioning
of this organ. Mechanisms regulating the expression and ac-
tivity of MMPs require further clarification.
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